Bisphosphonate Use Is Not Associated With Tuberculosis Risk Among Patients With Osteoporosis: A Nationwide Cohort Study

Bisphosphonates are considered an effective inhibitor of glutamine synthetase and thus can be used for treating tuberculosis (TB). However, its clinical benefit in TB remains unknown. We conducted a population‐based cohort study by using the Taiwan National Health Insurance Research Database and TB...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of clinical pharmacology 2022-11, Vol.62 (11), p.1412-1418
Hauptverfasser:	Chen, Jin‐Hua, Lee, Chih‐Hsin, Lee, Meng‐Rui, Huang, Pei‐Yu, Yen, Tzu‐Hsin, Lee, Ming‐Chia, Tsai, Ching‐Wen, Wang, Jann‐Yuan, Lee, Jen‐Ai
Format:	Artikel
Sprache:	eng
Schlagworte:	Bisphosphonates Cohort analysis Fractures Glutamate-ammonia ligase Glutamine Immobilization National Health Insurance Research Database Osteoporosis Patients Population studies propensity score Risk factors Tuberculosis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!